4.45
Anteris Technologies Global Corp stock is traded at $4.45, with a volume of 143.25K.
It is down -3.47% in the last 24 hours and down -20.11% over the past month.
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
See More
Previous Close:
$4.61
Open:
$4.77
24h Volume:
143.25K
Relative Volume:
0.85
Market Cap:
$160.48M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-2.2493
EPS:
-1.9784
Net Cash Flow:
-
1W Performance:
+1.14%
1M Performance:
-20.11%
6M Performance:
+80.16%
1Y Performance:
+0.00%
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AVR
Anteris Technologies Global Corp
|
4.45 | 166.25M | 0 | 0 | 0 | -1.9784 |
![]()
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-08-25 | Initiated | Lake Street | Buy |
Jan-07-25 | Initiated | Barclays | Overweight |
Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
Jan-07-25 | Initiated | TD Cowen | Buy |
Anteris Technologies Global Corp Stock (AVR) Latest News
Will Anteris Technologies Global Corp. continue its uptrend2025 Winners & Losers & Free Safe Capital Growth Stock Tips - newser.com
Anteris Technologies Global Corp.’s volatility index tracking explainedJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com
How rising interest rates impact Anteris Technologies Global Corp. stockWeekly Profit Summary & Weekly Momentum Picks - newser.com
What does recent volatility data suggest for Anteris Technologies Global Corp.Dollar Strength & High Conviction Investment Ideas - newser.com
Is this a good reentry point in Anteris Technologies Global Corp.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com
How Anteris Technologies Global Corp. stock reacts to global recession fears2025 Volume Leaders & Weekly Stock Performance Updates - newser.com
How strong is Anteris Technologies Global Corp. stock balance sheetForecast Cut & Growth-Oriented Investment Plans - newser.com
What to expect from Anteris Technologies Global Corp. in the next 30 days2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Combining machine learning predictions for Anteris Technologies Global Corp.Weekly Risk Summary & Safe Entry Momentum Stock Tips - newser.com
How hedge fund analytics apply to Anteris Technologies Global Corp. stockJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Using data filters to optimize entry into Anteris Technologies Global Corp.July 2025 Gainers & Consistent Growth Equity Picks - newser.com
Investors bid Anteris Technologies Global (ASX:AVR) up AU$29m despite increasing losses YoY, taking five-year CAGR to 13% - simplywall.st
Is Anteris Technologies Global Corp. trending in predictive chart modelsJuly 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com
Anteris Technologies Global (NASDAQ:AVR) Earns Sell (E+) Rating from Weiss Ratings - MarketBeat
Tools to assess Anteris Technologies Global Corp.’s risk profileMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Will Anteris Technologies Global Corp. stock outperform growth indexes2025 Big Picture & Long-Term Growth Stock Strategies - newser.com
Will Anteris Technologies Global Corp. price bounce be sustainableMarket Performance Report & Technical Pattern Recognition Alerts - newser.com
Reviewing Anteris Technologies Global (NASDAQ:AVR) and Helius Medical Technologies (NASDAQ:HSDT) - Defense World
Will Anteris Technologies Global Corp. stock remain a Wall Street favoriteEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Intraday pattern recognizer results for Anteris Technologies Global Corp.July 2025 Decliners & Capital Efficient Trade Techniques - newser.com
How to interpret RSI for Anteris Technologies Global Corp. stock2025 Dividend Review & Long-Term Growth Portfolio Plans - newser.com
Is Anteris Technologies Global Corp. stock attractive for income investors2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com
Anteris Technologies Global Corp. stock prediction for this weekExit Point & Consistent Return Investment Signals - newser.com
Anteris Technologies Reports Changes in Securities Issuance - MSN
Anteris Technologies Says Patient Enrollment in Global Pivotal Registration Trial Expected to Begin in Q4 - 富途牛牛
What’s next for Anteris Technologies Global Corp. stock pricePortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Anteris Technologies Advances with Stockholder Approvals and PARADIGM Trial Update - MSN
Anteris Technologies Approves ASX Waiver Proposal - The Globe and Mail
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anteris Technologies Global Corp Stock (AVR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):